Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-Reduced trial

Published:2023-06 Issue:6 Volume:81 Page:522-530
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Tsutsui Hiroyuki,Sakamaki Hiroyuki,Momomura Shin-ichi,Sakata Yasushi,Kotobuki Yutaro,Linden Stephan,Reifsnider Odette S.,Rakonczai Pal,Stargardter Matthew,Murata Tatsunori,Hirase Tetsuaki,Nitta Daisuke

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. The annual global economic burden of heart failure;Cook;Int J Cardiol,2014

2. Estimating incidence of acute heart failure syndromes in Japan — an analysis from the KUNIUMI registry —;Fujimoto;Circ J,2021

3. The heart failure “pandemic” in Japan: reconstruction of health care system in the highly aged society;Isobe;JMA J,2019

4. Heart failure epidemiology and novel treatments in Japan: facts and numbers;Konishi;ESC Heart Fail,2016

5. 9-year trend in the management of acute heart failure in Japan: a report from the National Consortium of acute heart failure registries;Shiraishi;J Am Heart Assoc Cardiovasc Cerebrovasc Dis,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of empagliflozin in the treatment of Malaysian patients with chronic heart failure and preserved or mildly reduced ejection fraction;PLOS ONE;2024-08-23

2. Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan;Expert Review of Vaccines;2024-03-05

3. Cost‐Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States;Journal of the American Heart Association;2024-02-20

4. Empagliflozin cost‐effectiveness analysis in Japanese heart failure with mildly reduced and preserved ejection fraction;ESC Heart Failure;2023-11-15

5. Systematic Review of the Economic Evaluation of Sodium–Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure;Clinical Drug Investigation;2023-06-26